logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Applied Molecular Evolution


USPTO Granted Patents = 27

% Expired Patents = 33.3



Forward Citations = 450

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Jeffry Dean Watkins (13 out of 106 patents)

silverMedal Alain Philippe Vasserot (13 out of 98 patents)

bronzeMedal David Matthew Marquis (12 out of 27 patents)

4.  Debra Gardner (9 out of 12 patents)

5.  Michael W Lark (9 out of 11 patents)

6.  David M Knight (9 out of 101 patents)

7.  David J Shealy (9 out of 41 patents)

8.  Eric Michael Smith (9 out of 14 patents)

9.  Vedrana Stojanovic-Susulic (9 out of 18 patents)

10.  Jing Yang (9 out of 21 patents)

11.  Sheng-Jiun Wu (9 out of 36 patents)

12.  Raymond W Sweet (9 out of 47 patents)

13.  Bailin Liang (9 out of 14 patents)

14.  William D Huse (9 out of 60 patents)

15.  Yan Chen (8 out of 15 patents)


Core Competencies:
Anti-IL-6 Antibody
Rheumatoid Arthritis
Pen-Injector Device
CD20 Binding Molecules
Humanized Antibodies
Alphavbeta3-Specific Antibodies
Binding Affinity
Tumor-Specific Antibodies
Butyrylcholinesterase Variants
Surface Expression Libraries
Methods of Use
Compositions

27 patents:

1. 12065488 - Anti-IL-6 antibody (2024-08-20),
2. 11180549 - Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody (2021-11-23),
3. 9631016 - Pen-injector device containing anti-IL-6 antibodies (2017-04-25),
4. 9340613 - Anti-IL-6 antibodies, compositions, methods and uses (2016-05-17),
5. 8623365 - Aβ binding molecules (2014-01-07),
6. 8623362 - Anti-IL-6 antibodies (2014-01-07),
7. RE43672 - Anti-IL-6 antibodies, compositions, methods and uses (2012-09-17),
8. 8226611 - Anti-IL-6 antibodies, compositions, methods and uses (2012-07-24),
9. 8153125 - CD20 binding molecules (2012-04-10),
10. 8105597 - Aβ binding molecules (2012-01-31),
11. 8067003 - Methods of treating conditions using anti-IL-6 antibodies (2011-11-29),
12. 7740847 - Variant Fc regions (2010-06-22),
13. 7723484 - Anti-EGFR antibodies (2010-05-25),
14. 7667007 - αvβ3-specific antibodies (2010-02-23),
15. 7575747 - Aβ binding molecules (2009-08-18),
Company Overview
Applied Molecular Evolution, based in San Diego, CA, specializes in the development of innovative biotechnological solutions. The company focuses on harnessing the principles of molecular evolution to create advanced products and technologies, particularly in the fields of protein engineering and synthetic biology. Their research aims to address complex challenges in various sectors, including healthcare and environmental sustainability, by leveraging cutting-edge methodologies to enhance biological systems and processes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

27 Patents

#221 in San Diego, CA

#2,934 in California

#12,428 in US

#24,034 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Applied Molecular Evolution

Forward Citations = 450

32 inventors:

goldMedal Jeffry Dean Watkins (13 out of 106 patents)

silverMedal Alain Philippe Vasserot (13 out of 98 patents)

bronzeMedal David Matthew Marquis (12 out of 27 patents)

4.  Debra Gardner (9 out of 12 patents)

5.  Michael W Lark (9 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Applied Molecular Evolution. Retrieved from https://idiyas.com/company/applied-molecular-evolution

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…